GB202315017D0 - Powder for oral solution formulations - Google Patents
Powder for oral solution formulationsInfo
- Publication number
- GB202315017D0 GB202315017D0 GBGB2315017.0A GB202315017A GB202315017D0 GB 202315017 D0 GB202315017 D0 GB 202315017D0 GB 202315017 A GB202315017 A GB 202315017A GB 202315017 D0 GB202315017 D0 GB 202315017D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- powder
- oral solution
- solution formulations
- formulations
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229940059097 powder for oral solution Drugs 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2315017.0A GB202315017D0 (en) | 2023-09-29 | 2023-09-29 | Powder for oral solution formulations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2315017.0A GB202315017D0 (en) | 2023-09-29 | 2023-09-29 | Powder for oral solution formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202315017D0 true GB202315017D0 (en) | 2023-11-15 |
Family
ID=88696352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2315017.0A Pending GB202315017D0 (en) | 2023-09-29 | 2023-09-29 | Powder for oral solution formulations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202315017D0 (en) |
-
2023
- 2023-09-29 GB GBGB2315017.0A patent/GB202315017D0/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2592117B (en) | Oral solution cannabinoid formulations | |
IL290472A (en) | Oral pharmaceutical composition containing heterocyclic compound | |
IL292682A (en) | Oral formulation of x842 | |
IL283593A (en) | Oral formulations of branaplam | |
EP4122483A4 (en) | Oral pharmaceutical composition | |
GB202315017D0 (en) | Powder for oral solution formulations | |
EP4062913C0 (en) | Solid oral formulation of utidelone | |
EP4041263A4 (en) | Oral care composition comprising cuttlefish bone powder | |
GB2613211B (en) | Alkaline oral formulations | |
GB202308845D0 (en) | Fast release oral formulations i | |
GB202308846D0 (en) | Fast release oral formulations ii | |
GB202311981D0 (en) | Oral compositions | |
GB202307626D0 (en) | Pharmaceutical formulations | |
IL312055A (en) | Oral formulation | |
GB202406312D0 (en) | Oral formulations comprising nicotine salt | |
CA225363S (en) | Pouch for oral products | |
GB202312074D0 (en) | Oral composition for perimenopause | |
GB202315863D0 (en) | Formulations | |
GB202307059D0 (en) | Formulations | |
GB202216961D0 (en) | 5-meo-mt formulations | |
GB202319627D0 (en) | Diffusion-modifying pouch for oral products | |
GB202208809D0 (en) | Nicotine formulations | |
GB202204171D0 (en) | Novel formulations | |
GB202317287D0 (en) | Dental paste | |
GB202108168D0 (en) | Oral supplements |